semaglutide and cardiovascular Outcomes in Patients with Type 2 Diabetes semaglutide #tirzepatide #cardiovascularcomplications #bodyweight #diabetes

This coordinate can be calculated from the other two, like this: $$z = -(x + y)$$ So in fact \(x + y + z = 0\)

Acid Reflux as a Reported Side Effect in Clinical Trials Data from Zepbound and tirzepatide clinical trials recorded acid reflux or heartburn in approximately 9-15% of participants at therapeutic doses, with higher rates reported in some real-world observational studies

Semaglutide is administered as a once-weekly subcutaneous injection (under the skin) in the stomach, thigh, or upper arm

Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout

a Simultaneous participation in any other clinical trial receiving an investigational medicinal product b Patients who attended the final scheduled visit c Patients who completed treatment with assigned treatment according to the end-of-trial form d 412 patients were randomized and 411 were included in the FAS